Literature DB >> 2782374

Malignant lymphoma of the gastrointestinal tract and mesentery. A clinico-pathologic study of the significance of histologic classification. NHL Study Group of the Comprehensive Cancer Center West.

J H van Krieken1, R Otter, J Hermans, K van Groningen, P J Spaander, M M van de Sandt, J F Keuning, P M Kluin.   

Abstract

A series of 92 malignant lymphomas of the gastrointestinal tract and mesentery obtained from a population-based registry was studied to assess whether the newly defined concept of mucosa-associated lymphoma has clinical relevance. The cases were grouped according to localization; gastric, intestinal, and mesenteric lymphoma. All cases were reviewed histologically, graded according to the Working Formulation, and reclassified according to the Kiel classification, which was modified to include the categories low- and high-grade mucosa-associated lymphoma. Clinical data, as well as staging and follow-up data, were related to both the original diagnosis and the diagnosis after reclassification. The results showed that the distribution of the types of lymphoma is related to site: centroblastic lymphoma was predominant in the stomach, lymphoblastic in the bowel, and follicular centroblastic-centrocytic in the mesentery. Gastrointestinal lymphoma was disseminated in approximately 50% of the patients at presentation. Survival analysis revealed that classification according to the original Kiel classification and grading according to the Working Formulation provided important prognostic information, whereas introduction of mucosa-associated lymphoma as an entity did not. It was concluded that modification of current classifications to include a separate category for mucosa-associated lymphoma is not useful.

Entities:  

Mesh:

Year:  1989        PMID: 2782374      PMCID: PMC1879924     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  36 in total

1.  Primary malignant lymphoma of the colon and rectum. A histopathological and immunohistochemical analysis of 45 cases with clinicopathological correlations.

Authors:  N A Shepherd; P A Hall; P J Coates; D A Levison
Journal:  Histopathology       Date:  1988-03       Impact factor: 5.087

2.  Primary gastric non-Hodgkin's lymphomas in Japan.

Authors:  N Mohri
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

3.  Monoclonal small (well-differentiated) lymphocytic proliferations of the gastrointestinal tract resembling lymphoid hyperplasia: a neoplasm of uncertain malignant potential.

Authors:  J S Burke; K Sheibani; B N Nathwani; C D Winberg; H Rappaport
Journal:  Hum Pathol       Date:  1987-12       Impact factor: 3.466

4.  Primary B-cell gastric lymphoma--a reassessment of its histogenesis.

Authors:  M J Myhre; P G Isaacson
Journal:  J Pathol       Date:  1987-05       Impact factor: 7.996

5.  Nuclear DNA content and its prognostic value in lymphoma of the stomach.

Authors:  H Joensuu; K O Söderström; P J Klemi; E Eerola
Journal:  Cancer       Date:  1987-12-15       Impact factor: 6.860

6.  Gastrointestinal lymphomas. Immunohistologic study of 23 cases.

Authors:  F Berger; B Coiffier; C Bonneville; J Y Scoazec; J P Magaud; P A Bryon
Journal:  Am J Clin Pathol       Date:  1987-12       Impact factor: 2.493

7.  Malignant lymphoma of mucosa-associated lymphoid tissue.

Authors:  P G Isaacson; J Spencer
Journal:  Histopathology       Date:  1987-05       Impact factor: 5.087

8.  High-grade non-Hodgkin's lymphoma of B-cell type. I. Histopathology.

Authors:  P K Hui; A C Feller; K Lennert
Journal:  Histopathology       Date:  1988-02       Impact factor: 5.087

9.  Primary gastrointestinal non-Hodgkin's lymphomas. A retrospective clinicopathologic study of 150 cases.

Authors:  B Dragosics; P Bauer; T Radaszkiewicz
Journal:  Cancer       Date:  1985-03-01       Impact factor: 6.860

10.  Gastrointestinal lymphomas. Immunohistochemical studies on the cell of origin.

Authors:  W W Grody; J G Magidson; L M Weiss; E Hu; H A Warnke; K J Lewin
Journal:  Am J Surg Pathol       Date:  1985-05       Impact factor: 6.394

View more
  6 in total

Review 1.  The molecular biology of B-cell lymphoma: clinicopathologic implications.

Authors:  P M Kluin; J H van Krieken
Journal:  Ann Hematol       Date:  1991-04       Impact factor: 3.673

2.  Overexpression of DNA methyltransferase 1 as a negative independent prognostic factor in primary gastrointestinal diffuse large B-cell lymphoma treated with CHOP-like regimen and rituximab.

Authors:  Haifeng Zhao; L E Zhang; Shanqi Guo; Tian Yuan; Bing Xia; Lianyu Zhang; Yizhuo Zhang
Journal:  Oncol Lett       Date:  2015-03-13       Impact factor: 2.967

3.  Two phenotypically distinct B lymphocytes (IgMhighIgDlow and IgMlowIgDhigh) in chronic gastric ulcer in the rat.

Authors:  N Ohmiya; M Ito; M Ohbayashi; T Arisawa; H Goto; Y Tsukamoto; T Hayakawa; J Asai
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

4.  Different bcl-2 protein expression in high-grade B-cell lymphomas derived from lymph node or mucosa-associated lymphoid tissue.

Authors:  R Villuendas; M A Piris; J L Orradre; M Mollejo; R Rodriguez; M Morente
Journal:  Am J Pathol       Date:  1991-11       Impact factor: 4.307

5.  Immunophenotype classification and therapeutic outcomes of Chinese primary gastrointestinal diffuse large B-cell lymphoma.

Authors:  Zizhen Zhang; Yanying Shen; Danping Shen; Xingzhi Ni
Journal:  BMC Gastroenterol       Date:  2012-06-25       Impact factor: 3.067

6.  Precursor B lymphoblastic lymphoma involving the stomach.

Authors:  Masaya Iwamuro; Yoshinari Kawai; Yasuhide Yamawaki; Katsuyoshi Takata; Kazuhide Yamamoto
Journal:  Case Rep Gastrointest Med       Date:  2013-06-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.